Amylyx Pharmaceuticals Inc (AMLX)
Cost of Revenue
$20.06M
TTM · Period ending: · USD
AMLX Cost of Revenue
Latest reported$20.06Mperiod ending
Latest reported$20.06Mperiod ending
AMLX TTM Cost of Revenue ($17.79M → $20.06M)
TTM cost of revenue
High-resolution chart · PNG
AMLX cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 20,061,000 | |
| 20,202,000 | |
| 42,223,000 | |
| 42,115,000 | |
| 23,069,000 | |
| 30,554,000 | |
| 124,841,000 | |
| 134,201,000 | |
| 138,610,000 | |
| 136,564,000 | |
| 25,441,000 | |
| 18,902,000 | |
| 13,856,000 | |
| 8,276,000 | |
| 24,457,000 | |
| 35,030,000 | |
| 34,858,000 | |
| 45,787,000 | |
| 31,187,000 | |
| 17,793,000 |